Abstract
The design and synthesis of 4-(2-adamantyl)phenylalkylamines 1-4 are described and their antiproliferative activity against four different tumor cell lines is reported.
Keywords: C-2 substituted adamantane, 4-(2-adamantyl)phenylalkylamines, antiproliferative activity.
Letters in Organic Chemistry
Title:Synthesis and Cytotoxicity of 4-(2-Adamantyl)phenylalkylamines
Volume: 12 Issue: 5
Author(s): Ioannis Papanastasiou, Stefanos Riganas, George B. Foscolos, Andrew Tsotinis, Samar A. Akhtar, Mohsin A. Khan, Khondaker M. Rahman and David E. Thursto
Affiliation:
Keywords: C-2 substituted adamantane, 4-(2-adamantyl)phenylalkylamines, antiproliferative activity.
Abstract: The design and synthesis of 4-(2-adamantyl)phenylalkylamines 1-4 are described and their antiproliferative activity against four different tumor cell lines is reported.
Export Options
About this article
Cite this article as:
Papanastasiou Ioannis, Riganas Stefanos, B. Foscolos George, Tsotinis Andrew, A. Akhtar Samar, A. Khan Mohsin, M. Rahman Khondaker and E. Thursto David, Synthesis and Cytotoxicity of 4-(2-Adamantyl)phenylalkylamines, Letters in Organic Chemistry 2015; 12 (5) . https://dx.doi.org/10.2174/157017861205150509202419
DOI https://dx.doi.org/10.2174/157017861205150509202419 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Current Drug Targets Small Molecules for Immunomodulation in Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Targeted Cancer Therapies: Current Status and Future Directions (Guest Editors: Ioannis Starakis)]
Current Medicinal Chemistry Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
Current Topics in Medicinal Chemistry Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Current Pharmaceutical Design Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Progress in Synthesis and Antitumor Activities of Estradiol-linked Platinum Complex
Mini-Reviews in Medicinal Chemistry Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
Current Cancer Therapy Reviews Proteomics: Technologies for Protein Analysis
Current Drug Metabolism The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets Antitumor Activity of Oxali-Titanocene Y in Xenografted CAKI-1 Tumors in Mice
Letters in Drug Design & Discovery Defensins: Key Molecules in Ocular Surface Protection
Current Immunology Reviews (Discontinued) Construction and Analysis of mRNA and lncRNA Regulatory Networks Reveal the Key Genes Associated with Prostate Cancer Related Fatigue During Localized Radiation Therapy
Current Bioinformatics Mangiferin – a Bioactive Xanthonoid, not only from Mango and not just Antioxidant
Mini-Reviews in Medicinal Chemistry Compounds from Wild Mushrooms with Antitumor Potential
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets